Making cannabinoids work better: new delivery method boosts effectiveness

Researchers have developed a breakthrough method to solve one of the biggest challenges in cannabis medicine: getting cannabinoids into the body effectively. CBD and other cannabinoids are naturally oily molecules that don't dissolve well in water, making it difficult for the body to absorb and utilize them. This new protocol uses nano-micelles—tiny spherical structures (16-32 nm) made from cannabidiol, cyclodextrin, and polysorbate 80—to dramatically increase water solubility and bioavailability of cannabinoids. The formulation can be rigorously tested using liquid chromatography-mass spectrometry and advanced imaging techniques.

This innovation has significant implications for cannabis research and therapeutic development. The enhanced nano-micellar formulation enables faster systemic delivery and better penetration into the central nervous system, which is essential for studying behavioral and neurological effects in laboratory models. This means researchers can now conduct more precise behavioral pharmacology and in vivo neurophysiology studies in mice with improved accuracy and consistency. The improved solubility and delivery system could eventually lead to better cannabis-based medicines with more predictable dosing and faster onset of action.

For cannabis users and the medical field broadly, this represents progress toward more effective, reliable cannabinoid treatments. By solving the bioavailability problem, this technology could enable lower doses with stronger effects, reduce variability between batches, and support the development of standardized cannabis-based pharmaceuticals that deliver consistent therapeutic benefits.